(3E,5E)-3-[(3,4-dibromophenyl)methylidene]-5-[(2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-ylidene]-1-methylpiperidin-4-one |
binding affinity -9.5 kcal/mol, binding free energy -223.0 kcal/mol |
Severe acute respiratory syndrome coronavirus 2 |
|
(3E,5E)-3-[(3,4-dichlorophenyl)methylidene]-5-[(2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-ylidene]-1-methylpiperidin-4-one |
binding affinity -9.6 kcal/mol, binding free energy -217.1 kcal/mol |
Severe acute respiratory syndrome coronavirus 2 |
|
(3E,5E)-3-[(3,4-difluorophenyl)methylidene]-5-[(2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-ylidene]-1-methylpiperidin-4-one |
binding affinity -9.6 kcal/mol, binding free energy -197.9 kcal/mol |
Severe acute respiratory syndrome coronavirus 2 |
|
(3E,5E)-3-[(3,4-dihydroxyhenyl)methylidene]-5-[(2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-ylidene]-1-methylpiperidin-4-one |
binding free energy -228.5 |
Severe acute respiratory syndrome coronavirus 2 |
|
(3E,5E)-3-[(4-fluorophenyl)methylidene]-5-[(2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-ylidene]-1-methylpiperidin-4-one |
binding affinity -9.5 kcal/mol, binding free energy -194.1 kcal/mol |
Severe acute respiratory syndrome coronavirus 2 |
|
additional information |
curcumin derivatives with reliable ADME profile and high molecular binding potency as inhibitors of PLpro. High-affinity ligand-PLpro protein complexes involve residues Lys157, Glu161, Asp164, Arg166, Glu167, Met208, Pro247, Pro248, Tyr264, Tyr273 and Asp302 residues of PLpro |
Severe acute respiratory syndrome coronavirus 2 |
|
remdesivir |
binding affinity -8.8 kcal/mol, binding free energy -241.4 kcal/mol |
Severe acute respiratory syndrome coronavirus 2 |
|